Compounds > dacarbazine

dacarbazine and Carcinoma

dacarbazine has been researched along with Carcinoma in 39 studies

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19906 (15.38)18.7374
1990's4 (10.26)18.2507
2000's5 (12.82)29.6817
2010's22 (56.41)24.3611
2020's2 (5.13)2.80

Authors

AuthorsStudies
Barbot, M; Bergo, E; Caccese, M; Ceccato, F; Cerretti, G; Lombardi, G; Occhi, G; Padovan, M; Scaroni, C1
Burman, P; Dekkers, OM; Losa, M; McCormack, A; Petersenn, S; Popovic, V; Raverot, G; Theodoropoulou, M; Trouillas, J1
Assié, G; Batisse-Lignier, M; Bonnet, F; Borot, S; Bourcigaux, N; Bresson, D; Caron, P; Castinetti, F; Chabre, O; Chanson, P; Cloix, L; Cortet, C; Delemer, B; Desailloud, R; Gaillard, S; Garcia, C; Haissaguerre, M; Jouanneau, E; Jublanc, C; Lasolle, H; Lebrun-Frenay, C; Raverot, G; Reznik, Y; Sadoul, JL; Taillandier, L; Vasiljevic, A; Villa, C1
Ahmad, MM; Aldabas, BS; Aljoaib, NN; Almalki, MH; Alotaibi, MJ; Alshahrani, F; Wahedi, TS1
Burman, P; Dekkers, OM; McCormack, A; Petersenn, S; Popovic, V; Raverot, G; Trouillas, J1
Chen, H; Cheung, F; Chow, JP; Li Lung, M; Man, WY; Mao, M; Nicholls, J; Poon, RY; Tsao, SW1
Bozzao, A; De Sanctis, V; Enrici, RM; Lanzetta, G; Minniti, G; Osti, M; Romano, A; Scaringi, C; Valeriani, M1
Andersen, M; Bengtsson, D; Berinder, K; Burman, P; Feldt Rasmussen, U; Hoybye, C; Johannsson, G; Maiter, D; Petersson, M; Ragnarsson, O; Rasmussen, ÅK; Schrøder, HD; van der Lely, AJ1
Chen, TC; Cho, HY; Hofman, FM; Nguyen, J; Schönthal, AH; Singh, A; Wang, W; Wetzel, SJ1
Lasolle, H; Raverot, G1
Hoostal, S; Lou, E; Peterson, RA; SantaCruz, KS; Touma, W; Wiernik, A1
Arbaje, YM; Lozier, AP; Scheithauer, BW1
Back, W; Bode, H; Brockmann, MA; Hammes, HP; Lammert, A; Seiz, M; Thomé, C1
Assaker, R; Bernier, M; Borson-Chazot, F; Brue, T; Caron, P; Chabre, O; Chanson, P; Cornélius, A; Cortet-Rudelli, C; de Fraipont, F; Dufour, H; Figarella-Branger, D; François, P; Gaillard, S; Jouanneau, E; Muller, M; Passagia, JG; Raverot, G; Salenave, S; Sturm, N; Trouillas, J1
Cusimano, M; Gonzalez, R; Horvath, E; Kovacs, K; Lau, Q; Lloyd, R; Ortiz, LD; Scheithauer, BW; Syro, LV; Uribe, H1
Cangi, MG; Gill, AJ; Losa, M; Mazza, E; McCormack, A; Mortini, P; Motta, M; Reni, M; Talarico, A; Terreni, MR1
Aneja, R; Banerjee, S; Jaiswal, AS; Narayan, S; Ostrov, DA; Sarkar, FH1
Erickson, D; Fealey, M; Horvath, E; Kovacs, K; Kros, JM; Lau, Q; Lloyd, RV; Salehi, F; Scheithauer, BW1
Marucci, G1
Asano, S; Ishida, Y; Katakami, H; Matsuno, A; Mizutani, A; Murakami, M; Okinaga, H; Ozawa, Y; Takano, K; Yamazaki, K1
Deutschbein, T; Lahner, H; Mann, K; Matuszczyk, A; Moeller, LC; Petersenn, S; Unger, N; Yuece, A1
Freyschlag, CF; Janzen, E; Lohr, F; Schmieder, K; Seiz, M; Smolczyk, DR; Thomé, C; Tuettenberg, J; Weiss, C; Wenz, F1
Barlier, A; Barrie, M; Brue, T; Castinetti, F; Conte-Devolx, B; Dufour, H; Morange, I; Philippon, M; Taieb, D1
Fadul, CE; Horvath, E; Kovacs, K; Ortiz, LD; Rotondo, F; Scheithauer, BW; Syro, LV; Uribe, H1
Dixit, S; Hingorani, M; Rajaraman, C; Rowland-Hill, C; Salvage, D1
Heaney, AP; Lim, S; Maya, MM; Shahinian, H; Yong, W1
Hunter, K; Jones-Bolin, S; Klein-Szanto, A; Ruggeri, B; Zhao, H1
Chakravarti, A; Mehta, MP; Siker, ML1
Alvino, E; Bonmassar, E; Caporali, S; D'Atri, S; Levati, L; Ragone, G; Starace, G1
Foley, JF; Kessinger, A; Lemon, HM1
Calandra, DB; Chejfec, G; Foy, BK; Lawrence, AM; Paloyan, E1
Koĭnov, K; Tsvekova, V; Velikova, M1
Bonmassar, E; Leonetti, C; Lozupone, F; Tentori, L1
Chan, AT; Johnson, PJ; Kwan, WH; Lai, M; Leung, TW; Mok, TS; Yeo, W1
Titscher, R1
Barth, V; Schönfelder, M1
Schoen, HD; Wendt, T1
Burgess, M; Pasterz, R; Savaraj, N1
Petursson, SR1

Reviews

5 review(s) available for dacarbazine and Carcinoma

ArticleYear
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series.
    Expert review of endocrinology & metabolism, 2023, Volume: 18, Issue:2

    Topics: Adenoma; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide

2023
Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review.
    Hormones (Athens, Greece), 2017, Volume: 16, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms; Prolactinoma; Temozolomide

2017
Treatment of pituitary neoplasms with temozolomide: a review.
    Cancer, 2011, Feb-01, Volume: 117, Issue:3

    Topics: Adenoma; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Carcinoma; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Pituitary Neoplasms; Radiography; Temozolomide; Tumor Suppressor Proteins

2011
Temozolomide in aggressive pituitary adenomas and carcinomas.
    Clinics (Sao Paulo, Brazil), 2012, Volume: 67 Suppl 1

    Topics: Adenoma; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide

2012
Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
    Critical reviews in oncology/hematology, 2006, Volume: 60, Issue:2

    Topics: Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Oligodendroglioma; Salvage Therapy; Temozolomide; Tumor Suppressor Protein p14ARF; Tumor Suppressor Proteins

2006

Trials

2 trial(s) available for dacarbazine and Carcinoma

ArticleYear
Whole brain reirradiation and concurrent temozolomide in patients with brain metastases.
    Journal of neuro-oncology, 2014, Volume: 118, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cranial Irradiation; Dacarbazine; Disease Progression; Female; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Prospective Studies; Retreatment; Retrospective Studies; Temozolomide; Treatment Outcome

2014
Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Female; Humans; Male; Middle Aged; Nasopharyngeal Neoplasms; Temozolomide; Treatment Outcome

1998

Other Studies

32 other study(ies) available for dacarbazine and Carcinoma

ArticleYear
Initial pathology in aggressive pituitary tumours and carcinomas: 2b or not 2b?-that is the question.
    European journal of endocrinology, 2023, 04-05, Volume: 188, Issue:4

    Topics: Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms; Temozolomide

2023
Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas.
    European journal of endocrinology, 2017, Volume: 176, Issue:6

    Topics: ACTH-Secreting Pituitary Adenoma; Adult; Antineoplastic Agents, Alkylating; Carcinoma; Chemoradiotherapy; Cohort Studies; Dacarbazine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; France; Humans; Male; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Neoplasms; Practice Patterns, Physicians'; Prolactinoma; Retrospective Studies; Survival Analysis; Temozolomide; Tumor Burden

2017
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016.
    European journal of endocrinology, 2018, Volume: 178, Issue:3

    Topics: Adenoma; Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Carcinoma; Carmustine; Child; Child, Preschool; Cranial Irradiation; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Endocrinology; Europe; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Neoplasm Invasiveness; Neurosurgical Procedures; Pituitary Neoplasms; Societies, Medical; Surveys and Questionnaires; Temozolomide; Thalidomide; Tumor Suppressor Proteins; Young Adult

2018
PARP1 is overexpressed in nasopharyngeal carcinoma and its inhibition enhances radiotherapy.
    Molecular cancer therapeutics, 2013, Volume: 12, Issue:11

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Carcinoma; Cell Line; Cell Proliferation; Combined Modality Therapy; Dacarbazine; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred BALB C; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasms, Experimental; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Temozolomide; Tissue Array Analysis; Xenograft Model Antitumor Assays

2013
Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:4

    Topics: Adenoma; Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Biomarkers, Pharmacological; Biomarkers, Tumor; Carcinoma; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms; Prognosis; Temozolomide; Treatment Outcome; Tumor Suppressor Proteins; Young Adult

2015
Chemotherapeutic effect of a novel temozolomide analog on nasopharyngeal carcinoma in vitro and in vivo.
    Journal of biomedical science, 2015, Aug-19, Volume: 22

    Topics: Animals; Carcinoma; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Proteins; Temozolomide; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays

2015
Therapeutic innovations in endocrine diseases - part 3 : temozolomide and future therapeutics for aggressive pituitary tumors and carcinomas.
    Presse medicale (Paris, France : 1983), 2016, Volume: 45, Issue:6 Pt 2

    Topics: Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Forecasting; Humans; Pituitary Neoplasms; Temozolomide

2016
Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2017, Volume: 41

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma; Chemoradiotherapy; Dacarbazine; Humans; Male; Middle Aged; Pituitary Neoplasms; Temozolomide

2017
Supratentorial, extraventricular choroid plexus carcinoma in an adult: case report.
    Neurosurgery, 2009, Volume: 65, Issue:4

    Topics: Aged; Antineoplastic Agents, Alkylating; Brain; Carcinoma; Choroid Plexus; Choroid Plexus Neoplasms; Craniotomy; Dacarbazine; Drug Administration Schedule; Female; Humans; Lateral Ventricles; Magnetic Resonance Imaging; Neurosurgical Procedures; Radiotherapy; Temozolomide; Temporal Lobe; Treatment Outcome

2009
SOM230 (pasireotide) and temozolomide achieve sustained control of tumour progression and ACTH secretion in pituitary carcinoma with widespread metastases.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2010, Volume: 118, Issue:10

    Topics: Adrenocorticotropic Hormone; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Dacarbazine; Female; Humans; Middle Aged; Pituitary Neoplasms; Salvage Therapy; Somatostatin; Temozolomide; Treatment Outcome

2010
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:10

    Topics: ACTH-Secreting Pituitary Adenoma; Adult; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; DNA Methylation; Female; France; Humans; Male; Middle Aged; Neoplasm Invasiveness; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sequence Analysis, DNA; Temozolomide

2010
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases.
    European journal of endocrinology, 2010, Volume: 163, Issue:6

    Topics: Adenoma; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Female; Humans; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Prospective Studies; Salvage Therapy; Temozolomide

2010
DNA polymerase β as a novel target for chemotherapeutic intervention of colorectal cancer.
    PloS one, 2011, Feb-02, Volume: 6, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Caco-2 Cells; Carcinoma; Cell Line, Tumor; Colorectal Neoplasms; Dacarbazine; DNA Polymerase beta; Drug Synergism; Female; HCT116 Cells; HT29 Cells; Humans; Mice; Mice, SCID; Molecular Targeted Therapy; Organophosphates; Pyrimidinones; Temozolomide; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2011
MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas.
    Journal of neuro-oncology, 2011, Volume: 104, Issue:3

    Topics: Adenoma; Adolescent; Adult; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Pituitary Neoplasms; Promoter Regions, Genetic; Statistics as Topic; Temozolomide; Young Adult

2011
Treatment of pituitary neoplasms with temozolomide: A review.
    Cancer, 2011, Sep-01, Volume: 117, Issue:17

    Topics: Adenoma; Antineoplastic Agents, Alkylating; Carcinoma; Dacarbazine; Humans; Pituitary Neoplasms

2011
A mechanism of acquiring temozolomide resistance during transformation of atypical prolactinoma into prolactin-producing pituitary carcinoma: case report.
    Neurosurgery, 2011, Volume: 68, Issue:6

    Topics: Antineoplastic Agents, Alkylating; Carcinoma; Cell Transformation, Neoplastic; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Drug Resistance, Neoplasm; Fatal Outcome; Female; Humans; Immunohistochemistry; Middle Aged; Mutation; Pituitary Neoplasms; Prolactin; Prolactinoma; Temozolomide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2011
Treatment of advanced medullary thyroid carcinoma with a combination of cyclophosphamide, vincristine, and dacarbazine: a single-center experience.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2011, Volume: 119, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcitonin; Carcinoma; Carcinoma, Neuroendocrine; Cohort Studies; Cyclophosphamide; Dacarbazine; Female; Gastrointestinal Tract; Hospitals, University; Humans; Male; Middle Aged; Myelopoiesis; Neoplasm Staging; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Tumor Burden; Vincristine

2011
Prolonged administration of temozolomide in adult patients with anaplastic glioma.
    Anticancer research, 2011, Volume: 31, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Carcinoma; Dacarbazine; Disease Progression; Feasibility Studies; Female; Follow-Up Studies; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Time Factors

2011
Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment.
    Annales d'endocrinologie, 2012, Volume: 73, Issue:3

    Topics: Adult; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Dopamine Agonists; Hormone Replacement Therapy; Humans; Hyperprolactinemia; Hypophysectomy; Hypopituitarism; Male; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Neoplasm Recurrence, Local; Ophthalmoplegia; Pancreatic Neoplasms; Parathyroid Neoplasms; Pituitary Apoplexy; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins; Radiotherapy, Adjuvant; Remission Induction; Spinal Neoplasms; Temozolomide

2012
Hypernatremia-associated myelinolysis following the management of sepsis in a patient with glioblastoma treated with radiotherapy and temozolomide.
    Acta neurologica Belgica, 2013, Volume: 113, Issue:4

    Topics: Antineoplastic Agents; Brain Diseases; Brain Neoplasms; Carcinoma; Carcinoma, Papillary; Dacarbazine; Diabetes Mellitus; Fatal Outcome; Glioblastoma; Humans; Hypernatremia; Hypertension; Liver Diseases; Male; Middle Aged; Neoplasms, Second Primary; Radiotherapy, Conformal; Sepsis; Temozolomide; Thyroid Cancer, Papillary; Thyroid Neoplasms

2013
Temozolomide: a novel treatment for pituitary carcinoma.
    The Lancet. Oncology, 2006, Volume: 7, Issue:6

    Topics: Aged; Antineoplastic Agents, Alkylating; Carcinoma; Combined Modality Therapy; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Temozolomide; Treatment Outcome

2006
The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:7

    Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma; Colonic Neoplasms; Dacarbazine; Glioblastoma; Humans; Irinotecan; Mice; Mice, Nude; Neoplasm Metastasis; Receptors, Vascular Endothelial Growth Factor; Temozolomide; Xenograft Model Antitumor Assays

2006
AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition.
    Molecular pharmacology, 2008, Volume: 74, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Ataxia Telangiectasia Mutated Proteins; B-Lymphocytes; Breast Neoplasms; Carcinoma; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Female; HCT116 Cells; Humans; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Temozolomide

2008
Therapy of malignant APUD cell tumors. Effectiveness of DTIC.
    Cancer, 1983, Mar-01, Volume: 51, Issue:5

    Topics: Adenoma, Islet Cell; Adult; Aged; Apudoma; Carcinoid Tumor; Carcinoma; Dacarbazine; Female; Humans; Ileal Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Thyroid Neoplasms

1983
Parathyroid carcinoma: biochemical and pathologic response to DTIC.
    Surgery, 1984, Volume: 96, Issue:6

    Topics: Adult; Calcium; Carcinoma; Dacarbazine; Female; Humans; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms

1984
[Adjuvant chemotherapy in ovarian carcinoma. Preliminary results].
    Akusherstvo i ginekologiia, 1993, Volume: 32, Issue:1

    Topics: Adnexa Uteri; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bulgaria; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Dacarbazine; Female; Fluorouracil; Humans; Hysterectomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Vincristine

1993
Antitumor and antimetastatic effects of dacarbazine combined with cyclophosphamide and interleukin-2 in Lewis lung carcinoma (3LL).
    Cancer immunology, immunotherapy : CII, 1995, Volume: 41, Issue:6

    Topics: Animals; Antigens, CD; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Cytotoxicity, Immunologic; Dacarbazine; Drug Administration Schedule; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Immunologic Factors; Integrin alpha6; Interleukin-2; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Transplantation; T-Lymphocytes, Cytotoxic

1995
[Dacarbacinum (DTIC) and bronchogenic carcinoma (author's transl)].
    Wiener klinische Wochenschrift, 1978, Dec-22, Volume: 90, Issue:24

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Carcinoma; Carcinoma, Small Cell; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonectomy; Triazenes; Vitamin A

1978
[Study of procreation capacity of men after treatment of their malignant tumors (melanoblastoma, thyroid carcinoma) with ionizing radiation and cytostatic agents].
    Zentralblatt fur Chirurgie, 1990, Volume: 115, Issue:20

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cobalt Radioisotopes; Cyclophosphamide; Dacarbazine; Fertility; Fluorouracil; Humans; Male; Melanoma; Methotrexate; Radiotherapy Dosage; Sperm Count; Sperm Motility; Spermatozoa; Thyroid Neoplasms

1990
[The effect of chemotherapy on survival time in advanced breast carcinoma].
    Deutsche medizinische Wochenschrift (1946), 1989, Jun-16, Volume: 114, Issue:24

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Neoplasm Metastasis; Postoperative Care; Prednisone; Retrospective Studies; Time Factors; Vincristine

1989
Prognostic factors in metastatic carcinoma of unknown primary.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:11

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasms, Unknown Primary; Prognosis; Skin Neoplasms; Statistics as Topic; Tegafur; Vincristine

1986
Metastatic medullary thyroid carcinoma. Complete response to combination chemotherapy with dacarbazine and 5-fluorouracil.
    Cancer, 1988, Nov-01, Volume: 62, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apudoma; Carcinoma; Dacarbazine; Female; Fluorouracil; Humans; Thyroid Neoplasms

1988